GDD/ID Flashcards
Name 6 first tier metabolic investigations for IDD/GDD/ASD if red flags (CCMG 2022-2023)
If regression:
Ammonia, blood gase, lactate +/- lytes, AG (if seizures, LOC)
Plasma amino acids
Urine organic acids +/- mucopolysaccharides (if HSM, course facial feature)
Very long chain fatty acids
Total plasma homocysteine
Creatine panel (if hypotonia, movement disorders or seizures)
Copper, ceruloplasmin (if movement disorders)
CCMG - based on clinical presentation
What is the genetic test and indication for Rett Syndrome?
MECP2 testing
Mod-severe ID, clinical features (hand wringing, developmental regression and plateau consistent with Rett syndrome)
Name 2 additional genetic test to Fragile X and microarray for ID/GDD and their indication
MECP2 testing – moderate to severe ID, clinical features of Rett (hand wringing, developmental regression and plateau consistent with Rett syndrome)
Whole exome sequencing – if moderate to severe ID, syndromic features, negative first line testing
PTEN – macrocephaly if >98%ile, >2.5 SD
Karyotype – short stature, dysmorphic features
Diagnostic criteria for GDD
- Delays >2 developmental domains (speech/language, social/personal, gross or fine motor, cognition, activities of daily living) standard deviations below the mean with standardized tests
- Children <5 yo
Diagnostic criteria for IDD
o Cognitive impairment in both clinical and standardized testing (FSIQ <70 +/-5)
o Deficit in adaptive functioning (limits in one or more activities of daily life: communication, social participation, independent living, across multiple environments) to the extend sufficient for ongoing support
o Onset in developmental period
Diagnostic yield of microarray in IDD/GDD?
8-20% by CPS
12-19% in mild, 20-30% in severe ID CCMG
List 6 benefits of identifying aetiology in GDD by microarray/CMA?
o Timely initiation of causal treatment or supportive management
o Prevention of complications
o Improved prognostication
o Accurate genetic counselling regarding recurrence risk, and prenatal/preimplantation genetic diagnosis when indicated
o Better access to services in the community
o Resolution of a diagnostic odyssey or avoidance of inappropriate, costly, and traumatizing tests
List 6 indications for MRI in IDD?
- Micro/macrocephaly
- Abnormal neurological exam (pyramidal/extra-pyramidal symptoms): Focal findings/ asymmetry, Abnormal tone, Abnormal movements (dystonia, chorea, athetosis, ataxia, rigidity…), Abnormal eye movements, Abnormal fundi
- Developmental regression
- Seizures
- Altered LOC
3 next steps in GDD/ID if microarray has non-specific findings or normal?
- Complete Tier 1 testing, consider Tier 2 testing
- Genetics referral
- Follow
- MRI
- Genetics referral for exome sequencing
- Family testing if VUS
Level of functioning/prognosis by severity of IDD?
Name 5 differences between GDD and ASD in early development
Name 3 single gene disorders associated with IDD ?
Fragile X (FMR1 gene with repeats), Rett syndrome (MECP2), Tuberous sclerosis (TSC1/2)
name 5 X-linked IDD syndromes
Fragile X
X linked adrenoleukodystrophy
Rett syndrome
MECP2 duplication syndrome
Lesch-Nyhan syndrome
Duchenne muscular dystrophy
OTC deficiency
Menkes disease
Alpha-thalassemia ID
Incontinentia pigmenti
Dyskeratosis congenita
Cornelia de lange – x linked dominant
Name 5 treatable IEM that cause GDD
Maple syrup urine disease
PKU
Homocysteinuria
Galactosemia
Biotinidase deficiency
Glutaric acidemia
Isovaleric acemia
Methymalonic acidemia
Citrin deficiency
Glutamine synthetase deficiency
OTC deficiency
X-linked adrenoleukodystrophy
Name 5 neurological features of IEM
- Micro/macrocephaly
- Hypotonia
- Movement disorder – ie dystonia
- Facial dysmorphisms
- Sensory deficits – ie cataracts, retinopathy
- Absent or brisk reflexes
- Positive Babinski
- Abnormal gait or inability to walk at developmental age
- Cataracts
- Abnormal smell